HOME >> BIOLOGY >> NEWS
Sex selection for social reasons unlikely to skew gender balance in Germany and UK

Allowing sex selection for social reasons would be highly unlikely to skew the gender balance at least in Germany and the UK according to new research published today (Thursday 25 September) in Europe's leading reproductive medicine journal Human Reproduction[1].

Surveys of more than 1,000 men and women in each country did reveal differences between the two countries, with the British expressing stronger gender preferences and the Germans being more relaxed about the sex of their children. The UK respondents were also much keener than the Germans on the idea of using reproductive technology to choose the sex of their babies.

But, as more than two thirds of the British expressed a wish to have an equal number of boys and girls anyway, the researchers concluded that these preferences would prevent any gender imbalances from happening in the UK if sex selection for social reasons is ever allowed.[2]

Lead investigator Dr Edgar Dahl, a bioethics specialist and research fellow at the Medical Center of the University of Giessen in Germany, said preconception sex selection for non-medical reasons raised serious moral, legal and social issues. The main concern was based on the assumption that a freely available sex selection service would distort the natural sex ratio. But, for a severe gender imbalance to occur there would have to be two conditions met a significant preference for children of a particular sex and a considerable demand for preconception sex selection.

The researchers used a randomised computer assisted telephone interview system to question representative samples of the German and UK populations 1,094 men and women aged 18 to 45 in Germany and 1,001 men and women aged 18 and older in the UK.

In Germany (excluding the small percentage of undecided):

  • 58% said they did not care about the sex of their children,
  • 30% said they wanted an equal number of boys and girls,
  • 4%
    '"/>


Contact: Margaret Willson
m.willson@mwcommunications.org.uk
45-3252-3334
European Society for Human Reproduction and Embryology
24-Sep-2003


Page: 1 2 3

Related biology news :

1. Hunting illusive signs of natural selection
2. Natural selection at work in genetic variation to taste
3. Salt-tolerant rice requires careful selection
4. Natural selection in a nutshell
5. Habitat loss and reserve network selection
6. Natural selections fingerprint identified on fruit fly evolution
7. Mathematical analysis could aid flu vaccine selection
8. Human and fly studies tally good and bad mutations, stress ongoing role of natural selection
9. New research confirms that natural selection is acting on the current human population
10. Natural selection for lactose tolerance
11. Building better engines through natural selection

Post Your Comments:
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 To ... biometric security provider HYPR Corp. announced today the addition of ... will serve as board advisor and David Raviv ... to the team underscore HYPR Corp.,s commitment to providing the ... , Dimitri Sirota co-founded Layer 7 Technologies, a ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... applications and designed for continuous operation up to 1500 bar. The sanitary design ... efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal ...
(Date:7/29/2015)... SYDNEY , July 29, 2015 US-Australian ... NVGN ) today confirmed it is committed to progressing ... as soon as practicable and to ensure the Company ... Chief Executive Officer, Iain Ross , said the ... including the lead pre-clinical programs, discovery programs and academic ...
(Date:7/29/2015)... , July 29, 2015  AsureQuality and ... molecular testing for applications in food and primary ... battery powered real-time PCR device, the Freedom4. ... right through to the supermarket shelf for producers, ... includes involvement in animal disease control and pest ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
Cached News: